A diabetes drug has been approved by a UK regulator to help obese and overweight adults lose weight. Patients with weight-related health problems - such as prediabetes, high blood pressure, high cholesterol or heart problems - will have access to the drug Mounjaro privately after it was approved by the Medicines and Healthcare Products Regulatory Agency . It needs further approval from the National Institute for Health and Care Excellence to be made available on the NHS.
The second showed patients with Type-2 diabetes lost 15.7% of their body weight over 72 weeks. The trials showed patients treated with Mounjaro 'had a significant weight loss over time compared to patients who took a placebo'. The agency listed the potential side effects of the medicine, including nausea, diarrhoea, vomiting - which usually goes away over time - and constipation. Low blood sugar is also 'very common' in patients with diabetes, it added.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study links gene network and pancreatic beta cell defects to type 2 diabetesA comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to type 2 diabetes. The study, published Nov.
Source: medical_xpress - 🏆 101. / 51 Read more »
Boosting beta cells to treat type 2 diabetesResearchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes.
Source: medical_xpress - 🏆 101. / 51 Read more »
Research brings the prospect of injection-free treatment closer for people with diabetesA University of Alberta team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient's own stem cells, bringing the prospect of injection-free treatment closer for people with diabetes.
Source: NewsMedical - 🏆 19. / 71 Read more »
Artificial Pancreas Systems: The Future of Diabetes Management?An APS is an advanced medical technology to help patients manage their blood sugar levels.
Source: NewsMedical - 🏆 19. / 71 Read more »
AGA does not endorse all patients stopping popular diabetes and weight loss drugs prior to endoscopyThe American Gastroenterological Association (AGA) has released a rapid clinical practice update addressing the management of patients taking glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1 RAs) prior to endoscopy.
Source: medical_xpress - 🏆 101. / 51 Read more »
Probiotics paired with metformin could be a game-changer in type 2 diabetes controlProbiotic supplementation shows promise in managing type 2 diabetes by improving glycemic control, particularly when combined with metformin, although results vary based on probiotic composition and regimen.
Source: NewsMedical - 🏆 19. / 71 Read more »